A Disease Progression Model to Quantify the Nonmotor Symptoms of Parkinson's Disease in Participants With Leucine-Rich Repeat Kinase 2 Mutation (2021)
Attributed to:
Joint Wellcome and MRC Centre, ‘Wellcome Trust – Medical Research Council Cambridge Stem Cell Institute’
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1002/cpt.2277
PubMed Identifier: 33894056
Publication URI: http://europepmc.org/abstract/MED/33894056
Type: Journal Article/Review
Parent Publication: Clinical Pharmacology & Therapeutics
Issue: 2
ISSN: 0009-9236